Skip to main content

L55 (Erlotinib 25 mg)

Pill with imprint L55 is White, Round and has been identified as Erlotinib 25 mg. It is supplied by Alembic Pharmaceuticals Inc.

Erlotinib is used in the treatment of non-small cell lung cancer; pancreatic cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Erlotinib 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L55

Erlotinib

Imprint
L55
Strength
25 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
EGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Alembic Pharmaceuticals Inc.
National Drug Code (NDC)
62332-0565

Get help with Imprint Code FAQs.

Related images for "L55"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.